Device brand name · Syringe antistick
VanishPoint: medical device reports filed with FDA
187 reports name it, 2002–2026. Manufacturer given most often on reports: Retractable Technologies. Product code MEG.
- 187
- device reports naming the brand
- 0% of all MAUDE reports · about 8 a year
- 9
- reports, 12 months to August 2026
- 14 in the 12 months before
- 95.7%
- classified as malfunction
- 88.1% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
187 medical device reports received by FDA name the brand "VanishPoint" (syringe antistick); the manufacturer given most often on reports is Retractable Technologies; received from January 2002 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
9 reports arrived in the 12 months to August 2026, down 36% from 14 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (95.7%) and other (1.6%); across all syringe, antistick reports (product code MEG) death is recorded in 0% and malfunction in 88.1%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are retraction problem (19.3%), fluid/blood leak (7%) and leak/splash (5.9%). The patient problems coded most often are needle stick/puncture, chemical exposure and exposure to body fluids. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 2,952 reports carrying product code MEG. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Retraction problem | 36 | 19.3% | 10.6% |
| Fluid/blood leak | 13 | 7% | 3.9% |
| Leak/splashthe device leaked | 11 | 5.9% | 17.6% |
| Device operates differently than expectedthe device behaved unexpectedly | 6 | 3.2% | 1.8% |
| Material twisted/bent | 6 | 3.2% | 1.2% |
| Device contaminated during manufacture or shipping | 5 | 2.7% | 1.6% |
| Fail-safe problem | 5 | 2.7% | 3% |
| Defective devicethe device was defective | 4 | 2.1% | 2.2% |
| Device markings/labelling problema problem with the device markings or label | 4 | 2.1% | 1.3% |
| Fail-safe did not operate | 4 | 2.1% | 0.3% |
| Breakthe device broke | 2 | 1.1% | 13.1% |
| Contamination /decontamination problem | 2 | 1.1% | 0.2% |
| Detachment of device or device componentpart of the device came off | 2 | 1.1% | 3.2% |
| Device contamination with chemical or other material | 2 | 1.1% | 2.5% |
| Noise, audible | 2 | 1.1% | 0.1% |
| Premature activation | 2 | 1.1% | 0.8% |
| Therapeutic or diagnostic output failure | 2 | 1.1% | 0.3% |
| Backflow | 1 | 0.5% | 0% |
| Bent | 1 | 0.5% | 1.2% |
| Component missing | 1 | 0.5% | 0.8% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Needle stick/puncture | 4 | 2.1% |
| Chemical exposure | 3 | 1.6% |
| Exposure to body fluids | 3 | 1.6% |
| Painpain, site not specified | 3 | 1.6% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 2 | 1.1% |
| No patient involvement | 2 | 1.1% |
| Anxietyanxiety | 1 | 0.5% |
| Hyperglycemiahigh blood sugar | 1 | 0.5% |
| Swellingswelling | 1 | 0.5% |
| Underdoseless than the intended dose | 1 | 0.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | VanishPoint | Product code MEG | All MAUDE reports |
|---|---|---|---|
| Reports | 187 | 2,952 | 26,136,888 |
| Share of that pool | — | 6.3% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 0% | 8.7% | 36.2% |
| Classified as malfunction | 95.7% | 88.1% | 62.3% |
| Filed by the manufacturer | 13.9% | 80.6% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MEG
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Bd Integra Syringe With Detachable Needle | 254 | 0 | 0% |
| Sol-Millennium | 341 | 5 | 0% |
| BD SafetyGlide | 576 | 127 | 0% |
| Bd Insulin Syringe With The Bd Ultra-Fine Needle | 869 | 0 | 0% |
| Jelco | 363 | 34 | 0% |
| Monoject | 430 | 14 | 0.2% |
| Bd Precisionglide Needle | 1,229 | 0 | 0% |
| Magellan | 330 | 20 | 0% |
| Portex | 970 | 8 | 0.6% |
| Bd Insulin Syringes With Bd Ultra-Fine Needle | 240 | 0 | 0% |
| Spectrum Infusion Pump | 147,363 | 15 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about VanishPoint reports
How many FDA reports name VanishPoint?
187 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 9 in the latest 12 months.
What kinds of events are reported?
malfunction (95.7%) and other (1.6%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
retraction problem (19.3%), fluid/blood leak (7%), leak/splash (5.9%), device operates differently than expected (3.2%) and material twisted/bent (3.2%). These are FDA's device problem codes as entered on the report.
Who files these reports?
voluntary reports (17.1%) and manufacturer reports (13.9%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that VanishPoint was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.